These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 6087160
21. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. Hemmings HC, Greengard P. J Neurosci; 1986 May; 6(5):1469-81. PubMed ID: 3711991 [Abstract] [Full Text] [Related]
27. Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2. Huang HB, Horiuchi A, Watanabe T, Shih SR, Tsay HJ, Li HC, Greengard P, Nairn AC. J Biol Chem; 1999 Mar 19; 274(12):7870-8. PubMed ID: 10075680 [Abstract] [Full Text] [Related]
28. DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein. Primary structure and homology with protein phosphatase inhibitor-1. Williams KR, Hemmings HC, LoPresti MB, Konigsberg WH, Greengard P. J Biol Chem; 1986 Feb 05; 261(4):1890-903. PubMed ID: 3511054 [Abstract] [Full Text] [Related]
29. Na+,K(+)-ATPase phosphorylation in the choroid plexus: synergistic regulation by serotonin/protein kinase C and isoproterenol/cAMP-PK/PP-1 pathways. Fisone G, Snyder GL, Aperia A, Greengard P. Mol Med; 1998 Apr 05; 4(4):258-65. PubMed ID: 9606178 [Abstract] [Full Text] [Related]
30. The role of DARPP-32 in the actions of drugs of abuse. Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. Neuropharmacology; 2004 Apr 05; 47 Suppl 1():14-23. PubMed ID: 15464122 [Abstract] [Full Text] [Related]
31. Ontogeny of the dopamine and cyclic adenosine-3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system. Foster GA, Schultzberg M, Kökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P. Int J Dev Neurosci; 1988 Apr 05; 6(4):367-86. PubMed ID: 2903614 [Abstract] [Full Text] [Related]
32. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC, Nairn AC, Greengard P. Nature; 1999 Dec 09; 402(6762):669-71. PubMed ID: 10604473 [Abstract] [Full Text] [Related]
33. Distribution of protein phosphatase inhibitor-1 in brain and peripheral tissues of various species: comparison with DARPP-32. Hemmings HC, Girault JA, Nairn AC, Bertuzzi G, Greengard P. J Neurochem; 1992 Sep 09; 59(3):1053-61. PubMed ID: 1353788 [Abstract] [Full Text] [Related]
38. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra. Tsou K, Snyder GL, Greengard P. Proc Natl Acad Sci U S A; 1993 Apr 15; 90(8):3462-5. PubMed ID: 8386374 [Abstract] [Full Text] [Related]
39. The phosphorylation state of DARPP-32, a third messenger for dopamine, is regulated by in vivo pharmacological treatments. Di Luca M, Cimino M, Cattabeni F. Neurochem Int; 1992 Mar 15; 20 Suppl():165S-170S. PubMed ID: 1365418 [Abstract] [Full Text] [Related]
40. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. Snyder GL, Girault JA, Chen JY, Czernik AJ, Kebabian JW, Nathanson JA, Greengard P. J Neurosci; 1992 Aug 15; 12(8):3071-83. PubMed ID: 1494946 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]